Skip to content

Clinical study on the prevention of myopia progression in children with 650nm low-intensity single-wavelength red light

Clinical study on the prevention of myopia progression in children with 650nm low-intensity single-wavelength red light

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048406
Enrollment
Unknown
Registered
2021-07-06
Start date
2021-07-10
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

group 1:650nm low-intensity single-wavelength red light feeder
group 2:0.01% atropine eye drops

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged 6 to 12 years; 2. Equivalent spherical lens degree: +0.50~ -0.75D, astigmatism less than -1.0D; 3. Vision greater than or equal to 1.0; 4. Intraocular pressure 10-21mmHg; 5. No active eye inflammation, no history of eye trauma, no history of eye surgery, no systemic and eye organic lesions.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of photosensitivity, glaucoma, blue eye syndrome, ocular hypertension, fundus macular degeneration or loss, albinism, psoriasis, nephrotic syndrome, systemic lupus erythematosus, diabetes and other immune system and systemic diseases ; 2. Have active ocular inflammation, history of ocular trauma, history of ocular surgery, systemic and ocular organic lesions; 3. It is not recommended to use atropine products at the same time due to the problem of light sensitivity.

Design outcomes

Primary

MeasureTime frame
refraction diopter;axial length;amplitude of accommodation;pupil diameter;choroid thickness;chororoid blood flow density;

Countries

China

Contacts

Public ContactFu Aicun

The First Affiliated Hospital of Zhengzhou University

fuaicun2019@qq.com+86 15093272336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026